EUVIMEDEUVIMED entdecken
Open Access

Novel inhibitory effect of Omega-3 fatty acids regulating pancreatic cancer progression

María I Garay, Tamara Mazo, Victoria Ferrero, Nelso N Barotto, Clarisa Lagares, María F Granton, María J Moreira-Espinoza, David C Cremonezzi, Andrea Comba, Mabel N Brunotto, Ezequiel J Tolosa, Martín E Fernandez-Zapico iD und 1 weitere

Carcinogenesis · 2025

DOI: 10.1093/carcin/bgae081 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Carcinogenesis, 2025. Verfasst von María I Garay und 12 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Investigaciones en Ciencias de la Salud, INICSA (CONICET - FCM UNC), 5016 Córdoba, Argentina. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Fatty Acids, Omega-3, Docosahexaenoic Acids, Liver Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Agencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación, NINDS NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic cancer is a devastating malignancy in great need of new and more effective treatment approaches. In recent years, studies have indicated that nutritional interventions, particularly nutraceuticals, may provide novel avenues to modulate cancer progression. Here, our study characterizes the impact of ω-3 polyunsaturated fatty acids, eicosapentaenoic acid, and docosahexaenoic acid, as a nutraceutical intervention in pancreatic cancer using a genetically engineered mouse model driven by KrasG12D and Trp53R172H. This model closely resembles human pancreatic carcinogenesis, offering a disease relevant platform for translational research. Our findings showed that ω-3 polyunsaturated fatty acids intervention (using a diet supplemented with 6% cod liver oil) significantly reduced tumor volume as well as lung and liver metastasis and a trend toward improved survival rate compared with control treated mice. This antitumoral effect was accompanied by distinct changes in tumor membrane fatty acid profile and eicosanoids release. Furthermore, the eicosapentaenoic acid and docosahexaenoic acid intervention also reduced malignant histological parameters and induced apoptosis without affecting cell proliferation. Of note is the significant reduction in tumor fibrosis that was associated with decreased levels of Sonic Hedgehog, a major ligand controlling this cellular compartment in pancreatic cancer. All together our results demonstrate the impact of eicosapentaenoic acid and docosahexaenoic acid as antitumor regulators in pancreatic cancer, suggesting potential for ω-3 polyunsaturated fatty acids as a possible antitumoral dietary intervention. This research opens new avenues for integrating nutraceutical strategies in pancreatic cancer management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsFatty Acids, Omega-3Docosahexaenoic AcidsLiver NeoplasmsAnimalsMiceDisease ProgressionHumansApoptosisCell ProliferationEicosapentaenoic AcidDietary SupplementsDisease Models, AnimalProto-Oncogene Proteins p21(ras)Lung NeoplasmsTumor Suppressor Protein p53

Stichwörter der Autor:innen

Sonic Hedgehognutraceutical interventionpancreatic cancerω-3 polyunsaturated fatty acids

Substanzen

Fatty Acids, Omega-3Eicosapentaenoic AcidDocosahexaenoic AcidsProto-Oncogene Proteins p21(ras)Tumor Suppressor Protein p53

Autor:innen und Institutionen

  • Instituto de Investigaciones en Ciencias de la Salud, INICSA (CONICET - FCM UNC), 5016 Córdoba, Argentina.
  • Instituto de Biología Celular y Cátedra de Biología Celular, Histología y Embriología, FCM-UNC, 5016 Córdoba, Argentina.
  • Departamento de Patología, Hospital Nacional de Clínicas, FCM-UNC, 5000 Córdoba, Argentina.
  • Department of Pathology, Division Neuropathology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, 35294, United States.
  • Departamento de Biología Bucal, Facultad de Odontología, UNC, 5016 Córdoba, Argentina.
  • Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, MN 55905, United States.

ORCID-Profile: Martín E Fernandez-Zapico, María E Pasqualini

Förderung

  • Agencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación
  • NINDS NIH HHS
  • NCI NIH HHS
  • Secretaría de Ciencia y Tecnología de la Universidad Nacional de Córdoba
  • Consejo Nacional de Investigaciones Científicas y Técnicas - Argentina
  • NIH

Zitieren

APA

Garay, M. I., Mazo, T., Ferrero, V., Barotto, N. N., Lagares, C., Granton, M. F., Moreira-Espinoza, M. J., Cremonezzi, D. C., Comba, A., Brunotto, M. N., Tolosa, E. J., Fernandez-Zapico, M. E., & Pasqualini, M. E. (2025). Novel inhibitory effect of Omega-3 fatty acids regulating pancreatic cancer progression. Carcinogenesis. https://doi.org/10.1093/carcin/bgae081

Vancouver

Garay MI, Mazo T, Ferrero V, Barotto NN, Lagares C, Granton MF, et al. Novel inhibitory effect of Omega-3 fatty acids regulating pancreatic cancer progression. Carcinogenesis. 2025. doi:10.1093/carcin/bgae081

BibTeX
@article{Garay2025,
  author = {Garay, María I and Mazo, Tamara and Ferrero, Victoria and Barotto, Nelso N and Lagares, Clarisa and Granton, María F and Moreira-Espinoza, María J and Cremonezzi, David C and Comba, Andrea and Brunotto, Mabel N and Tolosa, Ezequiel J and Fernandez-Zapico, Martín E and Pasqualini, María E},
  title = {Novel inhibitory effect of Omega-3 fatty acids regulating pancreatic cancer progression},
  journal = {Carcinogenesis},
  year = {2025},
  doi = {10.1093/carcin/bgae081}
}
Kostenlos starten →